Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
26.7%
% of XLV's 60 holdings also in FTXH
32.0%
% of FTXH's 51 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.5% | 7.5% | 7.5% |
|
ABBVIE INC | 6.9% | 7.4% | 6.9% |
|
MERCK & CO. INC. | 4.3% | 7.3% | 4.3% |
|
ELI LILLY & CO | 12.3% | 3.4% | 3.4% |
|
AMGEN INC | 3.1% | 3.7% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FTXH
|
UNITEDHEALTH GROUP INC | 9.0% |
|
ELI LILLY & CO | 8.9% |
|
ABBOTT LABORATORIES | 4.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
INTUITIVE SURGICAL INC | 3.3% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
DANAHER CORP | 2.5% |
|
STRYKER CORP | 2.4% |
 |
MEDTRONIC PLC | 2.1% |
|
ELEVANCE HEALTH INC | 1.9% |
XLV Underweight Relative to FTXH
|
BRISTOL-MYERS SQUIBB CO | -5.3% |
|
PFIZER INC | -4.5% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
VIATRIS, INC. | -3.3% |
|
BIOGEN IDEC INC | -3.3% |
|
JAZZ PHARMACEUTICALS PLC | -3.2% |
|
MERCK & CO. INC. | -3.0% |
|
ORGANON & CO. | -2.6% |
|
ZOETIS INC | -2.3% |
|
REGENERON PHARMACEUTICALS | -2.2% |